A scoping review of programme specific mammographic breast density related guidelines and practices within breast screening programmes
© 2023 The Authors..
Introduction: High mammographic breast density (MBD) is an independent breast cancer risk factor. In organised breast screening settings, discussions are ongoing regarding the optimal clinical role of MBD to help guide screening decisions. The aim of this scoping review was to provide an overview of current practices incorporating MBD within population-based breast screening programmes and from professional organisations internationally.
Methods: This scoping review was conducted in accordance with the framework proposed by the Joanna Briggs Institute. The electronic databases, MEDLINE (PubMed), EMBASE, CINAHL Plus, Scopus, and Web of Science were systematically searched. Grey literature sources, websites of international breast screening programmes, and relevant government organisations were searched to identify further relevant literature. Data from identified materials were extracted and presented as a narrative summary.
Results: The search identified 78 relevant documents. Documents were identified for breast screening programmes in 18 countries relating to screening intervals for women with dense breasts, MBD measurement, reporting, notification, and guiding supplemental screening. Documents were identified from 18 international professional organisations with the majority of material relating to supplemental screening guidance for women with dense breasts. Key factors collated during the data extraction process as relevant considerations for MBD practices included the evidence base needed to inform decision-making processes and resources (healthcare system costs, radiology equipment, and workforce planning).
Conclusions: This scoping review summarises current practices and guidelines incorporating MBD in international population-based breast screening settings and highlights the absence of consensus between organised breast screening programmes incorporating MBD in current breast screening protocols.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
European journal of radiology open - 11(2023) vom: 26. Dez., Seite 100510 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Driscoll, Jessica [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Breast cancer screening programme |
|---|
| Anmerkungen: |
Date Revised 11.08.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ejro.2023.100510 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360597572 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360597572 | ||
| 003 | DE-627 | ||
| 005 | 20231226083340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejro.2023.100510 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1201.xml |
| 035 | |a (DE-627)NLM360597572 | ||
| 035 | |a (NLM)37560166 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Driscoll, Jessica |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A scoping review of programme specific mammographic breast density related guidelines and practices within breast screening programmes |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.08.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. | ||
| 520 | |a Introduction: High mammographic breast density (MBD) is an independent breast cancer risk factor. In organised breast screening settings, discussions are ongoing regarding the optimal clinical role of MBD to help guide screening decisions. The aim of this scoping review was to provide an overview of current practices incorporating MBD within population-based breast screening programmes and from professional organisations internationally | ||
| 520 | |a Methods: This scoping review was conducted in accordance with the framework proposed by the Joanna Briggs Institute. The electronic databases, MEDLINE (PubMed), EMBASE, CINAHL Plus, Scopus, and Web of Science were systematically searched. Grey literature sources, websites of international breast screening programmes, and relevant government organisations were searched to identify further relevant literature. Data from identified materials were extracted and presented as a narrative summary | ||
| 520 | |a Results: The search identified 78 relevant documents. Documents were identified for breast screening programmes in 18 countries relating to screening intervals for women with dense breasts, MBD measurement, reporting, notification, and guiding supplemental screening. Documents were identified from 18 international professional organisations with the majority of material relating to supplemental screening guidance for women with dense breasts. Key factors collated during the data extraction process as relevant considerations for MBD practices included the evidence base needed to inform decision-making processes and resources (healthcare system costs, radiology equipment, and workforce planning) | ||
| 520 | |a Conclusions: This scoping review summarises current practices and guidelines incorporating MBD in international population-based breast screening settings and highlights the absence of consensus between organised breast screening programmes incorporating MBD in current breast screening protocols | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Breast cancer screening programme | |
| 650 | 4 | |a Evidence-based guidelines | |
| 650 | 4 | |a Mammographic breast density | |
| 650 | 4 | |a Scoping review | |
| 700 | 1 | |a Burke, Aileen |e verfasserin |4 aut | |
| 700 | 1 | |a Mooney, Therese |e verfasserin |4 aut | |
| 700 | 1 | |a Phelan, Niall |e verfasserin |4 aut | |
| 700 | 1 | |a Baldelli, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Alan |e verfasserin |4 aut | |
| 700 | 1 | |a Lynch, Suzanne |e verfasserin |4 aut | |
| 700 | 1 | |a Fitzpatrick, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Bennett, Kathleen |e verfasserin |4 aut | |
| 700 | 1 | |a Flanagan, Fidelma |e verfasserin |4 aut | |
| 700 | 1 | |a Mullooly, Maeve |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of radiology open |d 2014 |g 11(2023) vom: 26. Dez., Seite 100510 |w (DE-627)NLM246467290 |x 2352-0477 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2023 |g day:26 |g month:12 |g pages:100510 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejro.2023.100510 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2023 |b 26 |c 12 |h 100510 | ||